Indications for red cell transfusions in pediatric patients

Area of Science:

• Pediatric critical care medicine
• Transfusion medicine
• Hematology

Background:

• Red cell transfusions are a frequent intervention for critically ill children.
• Evidence supporting routine transfusions is limited, except for hemoglobinopathies like thalassemia and sickle cell anemia.
• Prophylactic transfusions are often based on expert opinion rather than robust data.

Purpose of the Study:

• To evaluate the efficacy and safety of red cell transfusions in critically ill children beyond established indications.
• To determine if liberal red cell transfusion prevents or causes adverse events like organ failure or stroke.
• To assess the relevance of adult transfusion trial data to pediatric populations, including neonates.

Main Methods:

• Review of epidemiologic evidence from adult randomized trials.
• Analysis of data from randomized trials in critically ill neonates and older children.
• Consideration of clinical practice combining laboratory data with signs of end-organ hypoxia.

Main Results:

• Limited evidence supports liberal red cell transfusion in critically ill neonates.
• Data suggest no benefit from liberal red cell transfusion in critically ill older children.
• Adult data indicate liberal transfusion may increase adverse events.

Conclusions:

• The benefits of red cell transfusions in critically ill children, outside of specific anemias, are uncertain.
• Current practice relies on a combination of laboratory values and clinical signs of hypoxia.
• More definitive randomized trial data are needed to guide transfusion practices in pediatrics.